Skip to main content
Log in

Changes in adrenal angiotensin II receptors in renindependent hypertensive rats

  • Research Articles
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

The changes in blood pressure may relate to the alterations of the responsiveness to vasoconstrictors and vasodilators, and these alterations can arise the modifications in the properties of angiotensin II (AII) receptor. In order to examine the changes of AII receptor in the hypertensive mechanism of renin-dependent hypertensive rats (RHRs; two-kidney, one-ligated type), we compared the equilibrium binding characteristics of [3H]All in adrenal cortex and medulla from RHRs and normotensive rats. The dissociation constants of All binding in both tissues of RHRs were very similar to those in the respective tissue of normotensive rats. However, the maximum binding was increased from 805 to 1050 fmole/mg protein in the adrenal cortex of RHRs, and decreased from 172 to 126 fmole/mg protein in the adrenal medulla of RHRs. These results imply that the up- and down-regulation of the All receptor population on the cell surface of adrenal glands from RHRs are consorted with the elevation of blood pressure and the activation of renin-angiotensin system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References Cited

  • Cangiano, J., Rodriguez-Sargent, C. and Martinez-Maldonado, M., Effects of antihypertensive treatment on systolic blood pressure and renin in experimental hypertension in rats.J. Pharmacol. Exp. Ther., 208, 310–313 (1979).

    PubMed  CAS  Google Scholar 

  • Chiu, A. T., McCall, D. E., Price, W. A., Wong, P. C., Carini, D. J., Duncia, J. V., Wexler, R. R., Yoo, S. E., Johnson, A. L. and Timmermans, P. B. M. W. M., Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.J. Pharmacol. Exp. Ther., 252, 711–718 (1990).

    PubMed  CAS  Google Scholar 

  • Devynck, M. A. and Meyer, P., Angiotensin receptors.Biochem. Pharmacol., 27, 1–5 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Douglas, J. G., Angiotensin receptor subtypes of the kidney cortex.Am. J. Physiol., 253, F1-F7 (1987).

    PubMed  CAS  Google Scholar 

  • Fernandes, M., Onesti, G., Weder, A., Oykyj, R., Gould, A. B., Kim, K. E. and Swartz, C., Experimental model of severe renal hypertension.J. Lab. Clin. Med., 87, 561–567 (1976).

    PubMed  CAS  Google Scholar 

  • Haber, E., Koerner, T., Page, L. B., Kliman B. and Purnode, A., Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.J. Clin. Endocrinol., 29, 1349–1355 (1969).

    Article  CAS  Google Scholar 

  • Lee, B. H. and Shin, H. S., In vivo pharmacological evaluation of newly synthesized nonpeptidic AT, receptor antagonist in rats.Arch. Pharm. Res. 17, 263–268 (1994).

    CAS  Google Scholar 

  • Lee, S., Lee, B., Shin, H. and Kong, J., Rat liver AT1 receptor binding analysis for drug screening.J. Appl. Pharmacol. 3, 21–27 (1995).

    Google Scholar 

  • Munson, P. J. and Rodbard, D., Ligand: a versatile computerized approach for characterization of ligand-binding systems.Anal. Biochem., 107, 220–239 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Peach, M. J. and Ackerly, J. A., Angiotensin antagonists and the adrenal cortex and medulla.Fed. Proc., 35, 2502–2507 (1976).

    PubMed  CAS  Google Scholar 

  • Peach, M. J., Renin-angiotensin system: biochemistry and mechanisms of action.Physiol. Rev., 57, 313–370 (1977).

    PubMed  CAS  Google Scholar 

  • Timmermans, P. B. M. W. M., Wong, P. C., Chiu, A. T., Herblin, W. F., Benfield, P., Carini, D. J., Lee, R. J., Wexler, R. R., Saye, J. A. M. and Smith, R. D., Angiotensin II receptors and angiotensin II receptor antagonists.Pharmacol. Rev., 45, 205–251 (1993).

    PubMed  CAS  Google Scholar 

  • Wiest, S. A., Rampersaud, A., Zimmerman, K. and Steinberg, M. I., Characterization of distinct angiotensin II binding sites in rat adrenal gland and bovine cerebellum using selective nonpeptide antagonists.J. Cardiovas. Pharmacol., 17, 177–184 (1991).

    Article  CAS  Google Scholar 

  • Wong, P. C., Price, W. A., Chiu, A. T., Duncia, J. V., Carini, D. J., Wexler, R. R., Johnson, A. L. and Timmermans, P. B.-M. W. M., Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.J. Pharmacol. Exp. Ther., 252, 726–732 (1990).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, S., Lee, B. & Shin, H. Changes in adrenal angiotensin II receptors in renindependent hypertensive rats. Arch. Pharm. Res. 18, 169–172 (1995). https://doi.org/10.1007/BF02979190

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02979190

Key words

Navigation